cardio Flashcards
narrow-complex tachycardias originate
within/above the AV node
wide-complex tachycardias originate
and one exception
below the AV node
(exception: SVT w/aberrancy, like a bundle branch block, rate-related conduction block, WPW, or a toxic-metabolic condition)
SVT: tx
- vagal: supine Valsalva
- adenosine 6-6-12 –> dilt + gtt
- synchronized cardioversion @100 J
tachyarrhythmia DDx: narrow, regular
sinus tach
aflutter
tachyarrhythmia DDx: narrow, irregular
afib w/wo variable block
multifocal atrial tachycardia
tachyarrhythmia DDx: wide, regular
VT
SVT w/aberrancy
tachyarrhythmia DDx: wide, irregular
torsades
SVT w/aberrancy
stable wide-complex tachycardia: tx
1st choice: amio 150 > gtt (or procainamide)
2nd choice: lido
don’t forget mag
unstable wide-complex tachyarrhythmia: tx
synchronized cardioversion @200 J
unstable narrow-complex tachyarrhythmia: tx
synchronized cardioversion @50 J
explain BRASH syndrome
bradycardia, renal failure, AV nodal blocker, shock, hyperK
- bradycardia causes renal hypoperfusion/failure, which causes hyperK, which synergizes w/accumulated AV nodal blockers to worsen bradycardia and shock, which worsens renal failure
THE KEY = hyperK synergizing w/AV nodal blockers to cause bradycardia
How is BRASH different from pure hyperK?
- degree of hyperK: the hyperK in BRASH is usually milder; for hyperK alone to create bradycardia requires a more dramatic K
- EKG w/only bradycardia (disproportionate): bradycardia w/o other EKG features of hyperK favors BRASH
How is BRASH different from pure AV nodal blocker intoxication?
- presence of hyperK
- history (BRASH pts are usually medication-adherent)
3 most common causes of BRASH
hypovolemia (GI loss, diuresis)
any cause of hypoperfusion
any cause of acute kidney injury
3 arms of BRASH tx
- hyperK meds: calcium, insulin/dextrose, albuterol
- IVF if hypovolemic: isotonic bicarb until acidosis resolves, then LR
- kaliuresis: Lasix 80-160 +/- chlorothiazide 500-1000, Diamox 250-500, or fludrocortisone 0.2 PO (especially if pt is on ACEi) –> HD if failure
pressor choice in BRASH and rationale
low-dose epi (up to 10 mcg/min) to hit beta-1 receptors –> inotropy, and beta-2 receptors –> K shifting
symptomatic non-tox narrow-complex bradycardia: tx
- EKG, pads, and atropine 0.5 mg q3-5m, max 6 doses
- careful if there’s ongoing ischemia
- avoid if it’s wide-complex - epi 2-10 mcg/min
- TCP
- TVP
etomidate dosing for cardioversion
- 1 mg/kg –> second dose 0.05 mg/kg just before shock
i. e. 8 mg –> 4 mg (80 kg), or 10 mg –> 5 mg (100 kg)
progression of EKG findings during an untreated OMI
hyperacute T waves STE Q wave (1-12h) or STE w/TWI (2-5d) T wave recovery (weeks-months) permanent STE (LV aneurysm morphology)
progression of EKG findings when an OMI is reperfused
terminal TWI which eventually becomes symmetric
eventual return to baseline EKG (hours-days)